Purple Agrotech Industries (540159)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at 42% of book value (P/B 0.42), offering a potential margin of safety if assets are fairly stated.
• Book value per share of ₹11.27 is substantially above the market price of ₹4.73.
• ROCE of 4.76% is positive, implying some operating assets generate modest returns despite weak earnings.
• Current price is closer to the 52-week low of ₹3.30 than the high of ₹8.20, reducing near-term downside if the business stabilizes.

Concerns

• Latest quarter shows sales of ₹0 Cr and a net loss, indicating no current operating earnings engine.
• Profit growth of -141.67% and Piotroski F-Score of 3/9 point to deteriorating fundamentals.
• Film production and exhibition assets are hard to value and may not be realizable at stated book value.
• P/E of 23.83 is meaningless given near-zero earnings, and zero dividend yield offers no income support.

AI Analysis

At first glance, this is the kind of stock Graham would call a cigar butt. The market price is ₹4.73, while book value stands at ₹11.27, giving a P/B of 0.42. Buying at 42 paise to the rupee of book value offers a margin of safety—if that book value is honest. But as Buffett, I don't buy assets; I buy businesses that generate returns. Purple Agrotech is in film production, distribution and exhibition, a business with no durable moat, no pricing power, and no predictable cash flows. The latest quarter shows sales of ₹0 Cr and a small net loss. Sales growth is flat, profit growth is -141.67%, and the Piotroski F-Score is a weak 3 out of 9. ROE is just 1.81% and ROCE 4.76%; these returns are far below what I would demand. The P/E of 23.83 is meaningless when earnings are nearly absent. With a market cap of only ₹4 Cr, this is a microcap, and in small illiquid names, the discount to book often remains, or gets worse. Dividend yield is zero, so the investor depends entirely on price re-rating or asset realization. Film libraries and production rights are notoriously difficult to value, especially in a declining theatrical environment. This looks more like a possible asset play than a compounder. At ₹4.73, there may be some downside cushion, but I would not take a meaningful position without independent verification of assets, a clear plan to unlock value, and evidence that promoters treat minority shareholders fairly. In Graham's language: a bargain only if book value is real and management is honest. I need more than a low P/B ratio.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer